Concepedia

Elisabeth Oelmann

EO

21

Publications

1K

Citations

18

H-Index

1993

Active since

Affiliations

Freie Universität Berlin(Current)

Franklin University

AstraZeneca (United Kingdom)

University of Münster

University Hospital Münster

Elisabeth Oelmann is an author at Freie Universität Berlin specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1993–2020

21

Publications

21

First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014

Bristi Basu, Emma Dean, M. Puglisi et al. · Clinical Cancer Research · 2015 · 126 citations

Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma

Aung Naing, Carol Aghajanian, Éric Raymond et al. · British Journal of Cancer · 2012 · 126 citations · Full text

Lymphotoxin, tumour necrosis factor and interleukin‐6 gene transcripts are present in Hodgkin and Reed‐Sternberg cells of most Hodgkin's disease cases

Hans‐Dieter Foss, Hermann Herbst, Elisabeth Oelmann et al. · British Journal of Haematology · 1993 · 101 citations

Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer

Peter Schmid, Catherine Harper‐Wynne, M. Ferreira et al. · JAMA Oncology · 2019 · 90 citations · Full text

Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells

Elisabeth Oelmann, Hermann Herbst, M. Zühlsdorf et al. · Blood · 2002 · 74 citations · Full text

Rows per page

1–5 of 21